"Next Generation Sequencing (NGS) Market Summary:
According to the latest report published by Data Bridge Market Research, the Next Generation Sequencing (NGS) Market
CAGR Value
The global next generation sequencing (NGS) market was valued at USD 15.98 billion in 2024 and is expected to reach USD 49.21 billion by 2032
During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 15.10%, primarily driven by continuous advancements in sequencing technologies and increasing clinical applications
The large scale Next Generation Sequencing (NGS) Marketing report studies and evaluates market drivers, market restraints, challenges, opportunities and key developments in the market. SWOT analysis has been used throughout the report which helps emphasize on the global key manufacturers, market definition, description and analysis of the market competition landscape. The market research data included in this Next Generation Sequencing (NGS) Market report is analysed and forecasted using market statistical and coherent models. It makes effortless for Next Generation Sequencing (NGS) Market industry to visualize what is already available in the market, what market anticipates, the competitive environment, and what should be done to surpass the competitor. This results into actionable ideas, better decision-making and better business strategies.
Stay informed with our latest keyword market research covering strategies, innovations, and forecasts. Download full report: https://www.databridgemarketresearch.com/reports/global-next-generation-sequencing-ngs-market
Next Generation Sequencing (NGS) Market Segmentation and Market Companies
Segments
- Based on technology, the NGS market can be segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, sequencing by ligation (SBL), pyrosequencing, single-molecule real-time (SMRT) sequencing, and others. Sequencing by synthesis technology is expected to dominate the market due to its high accuracy and efficiency in DNA sequencing.
- On the basis of application, the market can be divided into diagnostics, drug discovery, precision medicine, genetic screening, agriculture & animal research, and others. The diagnostics segment is expected to witness significant growth, driven by the increasing demand for personalized medicine and early disease detection.
- By end-user, the NGS market can be categorized into academic research centers, pharmaceutical & biotechnology companies, hospitals & clinics, and others. The pharmaceutical & biotechnology companies are expected to hold a major share in the market due to their focus on developing precision medicine solutions.
Market Players
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Qiagen
- F. Hoffmann-La Roche AG
- Agilent Technologies, Inc.
- BGI
- Bio-Rad Laboratories, Inc.
- Pacific Biosciences of California, Inc.
- PerkinElmer Inc.
- Oxford Nanopore Technologies
These market players are actively involved in strategic initiatives such as partnerships, collaborations, product launches, and acquisitions to strengthen their market position and expand their product offerings in the global NGS market. The market is highly competitive with key players focusing on technological advancements to enhance the efficiency and accuracy of NGS platforms.
The global next-generation sequencing (NGS) market is experiencing significant growth driven by advancements in technology, increasing applications across various industries, and a growing demand for personalized medicine solutions. In addition to the segments mentioned, there are emerging trends shaping the market dynamics. One such trend is the rising adoption of NGS in liquid biopsy for cancer detection and monitoring. Liquid biopsy offers a less invasive and more accessible method for early cancer detection, treatment selection, and monitoring treatment response, thereby driving the demand for NGS technologies in this space. Furthermore, the integration of artificial intelligence and machine learning algorithms with NGS data analysis is enhancing the speed and accuracy of genomic data interpretation, facilitating personalized treatment strategies and clinical decision-making.
Market players in the NGS industry are actively focusing on expanding their product portfolios and market presence through strategic collaborations and partnerships. For instance, Illumina, Inc., a key player in the market, has collaborated with various pharmaceutical companies to develop companion diagnostics for targeted therapies. This trend emphasizes the shift towards precision medicine and the need for NGS technologies to enable tailored treatment options based on individual genetic profiles. Additionally, companies like Thermo Fisher Scientific Inc. and Qiagen are investing in research and development to innovate new products that cater to the evolving needs of the NGS market, such as faster sequencing platforms, simplified workflows, and higher throughput.
Another factor driving the NGS market growth is the increasing investments in genomics research and government initiatives to promote genomic sequencing technologies. Countries like the United States, China, and European nations are investing heavily in genomics research initiatives to understand the genetic basis of diseases, accelerate drug discovery processes, and improve healthcare outcomes. This growing support for genomics research is fueling the demand for NGS technologies across academic research centers, pharmaceutical companies, and healthcare institutions. As a result, market players are focusing on providing cost-effective NGS solutions with high scalability and user-friendly interfaces to cater to the diverse needs of end-users across different sectors.
In conclusion, the global next-generation sequencing market is poised for substantial growth with technological advancements, expanding applications, and strategic collaborations driving innovation and market competitiveness. The convergence of NGS with other cutting-edge technologies like artificial intelligence and the increasing focus on precision medicine are set to revolutionize healthcare delivery and personalized treatment approaches, positioning NGS technologies as indispensable tools in the genomics era.The global next-generation sequencing (NGS) market is a highly competitive landscape dominated by key players such as Illumina, Thermo Fisher Scientific, Qiagen, and Roche. These companies are investing heavily in research and development to innovate new products and establish strategic collaborations to strengthen their market position. The market is driven by advancements in technology, increasing applications across various industries, and a growing demand for personalized medicine solutions. One of the emerging trends in the market is the rising adoption of NGS in liquid biopsy for cancer detection and monitoring, offering a less invasive and more accessible method for early cancer detection. This trend is expected to drive the demand for NGS technologies in the healthcare sector.
Moreover, the integration of artificial intelligence and machine learning algorithms with NGS data analysis is enhancing the speed and accuracy of genomic data interpretation, leading to personalized treatment strategies and clinical decision-making. Market players are actively focusing on expanding their product portfolios through strategic collaborations and partnerships. For instance, Illumina has collaborated with pharmaceutical companies to develop companion diagnostics for targeted therapies, emphasizing the shift towards precision medicine. Thermo Fisher Scientific and Qiagen are investing in research and development to innovate new products that meet the evolving needs of the NGS market, such as faster sequencing platforms and simplified workflows.
Another factor contributing to the growth of the NGS market is the increasing investments in genomics research and government initiatives to promote genomic sequencing technologies. Countries like the United States, China, and European nations are investing heavily in genomics research initiatives to accelerate drug discovery processes and improve healthcare outcomes. This growing support for genomics research is fueling the demand for NGS technologies across academic research centers, pharmaceutical companies, and healthcare institutions. Market players are focusing on providing cost-effective NGS solutions with high scalability and user-friendly interfaces to meet the diverse needs of end-users across different sectors.
In conclusion, the global NGS market is set for substantial growth with technological advancements, expanding applications, and strategic collaborations shaping the industry landscape. The convergence of NGS with other cutting-edge technologies like artificial intelligence and the increasing focus on precision medicine are expected to revolutionize healthcare delivery and personalized treatment approaches. NGS technologies are becoming indispensable tools in the genomics era, driving innovation and competitiveness in the market.
Learn about the company’s position within the industry
https://www.databridgemarketresearch.com/reports/global-next-generation-sequencing-ngs-market/companies
Frequently Asked Questions About This Report
How is Predictive Maintenance used in Next Generation Sequencing (NGS) Market facilities?
What is the growth potential of the [Niche Segment] within the Next Generation Sequencing (NGS) Market?
How is the Subscription Economy impacting Next Generation Sequencing (NGS) Market revenue?
Which technology segment had the highest valuation in the Next Generation Sequencing (NGS) Market in 2025?
How is the Next Generation Sequencing (NGS) Market affected by geopolitical tensions?
What is the influence of ISO standards on Next Generation Sequencing (NGS) Market quality?
How much is the Next Generation Sequencing (NGS) Market expected to grow in absolute dollar terms between 2025 and 2033?
What are the top 5 risks facing the global Next Generation Sequencing (NGS) Market?
What are the labor laws impacting Next Generation Sequencing (NGS) Market manufacturing?
How will the integration of [Technology] create new Next Generation Sequencing (NGS) Market niches?
How is the Next Generation Sequencing (NGS) Market segmented by end-use industry?
What was the revenue contribution of [Technology X] in the base year?
Browse More Reports:
Global Next Generation Sequencing (NGS) Market
Global Spirits Market
Global Sushi Restaurants Market
Global Jam, Jelly and Preserve Packaging Market
Global Sustainable Sportswear Market
Global Edible Oils Market
Europe Used Car Market
Global Methanol Market
Global Modular Construction Market
Europe Modular Construction Market
Global Fragrance Diffuser Market
Global Procurement Outsourcing Services Market
Global Arcade Gaming Market
Global Sesame Seeds Market
Global Core Banking Solutions Market
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 992
Email:- corporatesales@databridgemarketresearch.com"